ALASTAIR THOMPSON to Risk Assessment
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Risk Assessment.
Connection Strength
0.132
-
Mortality associated with the treatment of gallstone disease: a 10-year contemporary national experience. World J Surg. 2011 Mar; 35(3):643-7.
Score: 0.039
-
Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy. Breast Cancer Res Treat. 2011 Jan; 125(1):279-87.
Score: 0.038
-
Dissecting the molecular mechanisms of human cancer: translating laboratory advances into clinical practice. Surgeon. 2004 Feb; 2(1):1-6.
Score: 0.024
-
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct; 24 Suppl 6:vi7-23.
Score: 0.012
-
The impact of operative approach for oesophageal cancer on outcome: the transhiatal approach may influence circumferential margin involvement. Eur J Surg Oncol. 2012 Feb; 38(2):157-65.
Score: 0.010
-
Avoidance of CYP2D6 inhibitors in patients receiving tamoxifen. J Clin Oncol. 2010 Oct 10; 28(29):e584-5; author reply e586.
Score: 0.009